Finance

Beta
Lists
600085:SHA
Beijing Tong Ren Tang Co Ltd
CN¥25.03
+0.72%
(+0.18) 1D
Jun 5, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600085...
Open
CN¥24.84
High
CN¥25.38
Low
CN¥24.84
Mkt. cap
34.08B
Avg. vol.
7.11M
Volume
5.04M
P/E ratio
31.83
52-wk high
CN¥38.10
52-wk low
CN¥24.51
EPS
CN¥0.79
Shares outstanding
1.37B
No. of employees
17K
Open
CN¥24.84
High
CN¥25.38
Low
CN¥24.84
Mkt. cap
34.08B
Avg. vol.
7.11M
Volume
5.04M
P/E ratio
31.83
52-wk high
CN¥38.10
52-wk low
CN¥24.51
EPS
CN¥0.79
Shares outstanding
1.37B
No. of employees
17K
News stories
From sources across the web
Profile
Tong Ren Tang is a Chinese pharmaceutical company founded in 1669. It is now the largest producer of traditional Chinese medicine. The company headquarters are in Beijing, where they engage in both manufacturing and retail sales. It operates drug stores, predominantly in Chinese-speaking regions. Tong Ren Tang is considered one of the "Big 4" traditional Chinese medicine brands still in existence. The four companies include: Guangyuyuan, Guangzhou Chen Liji, Beijing Tong Ren Tang, and Hangzhou Hu Qing Yu Tang. Tong Ren Tang, and GuangYuYuan have been officially recognized as "China Time-Honored Brands" by the Ministry of Commerce of the People's Republic of China. Wikipedia
About Beijing Tong Ren Tang Co Ltd
CEO-
Employees17.3K
Founded1669
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.49B
3.54B
3.95B
4.66B
Cost of goods sold
2.63B
1.97B
2.50B
2.72B
Cost of revenue
2.63B
1.97B
2.50B
2.72B
Research and development expenses
53.06M
53.41M
144.52M
51.64M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.15B
1.10B
1.30B
1.13B
Operating expense
1.25B
1.16B
1.52B
1.23B
Total operating expenses
3.88B
3.13B
4.02B
3.95B
Operating income
615.02M
408.67M
-73.33M
709.73M
Other non operating income
-6.37M
-3.64M
-4.50M
-3.96M
EBT including unusual items
616.47M
346.57M
67.54M
748.37M
EBT excluding unusual items
609.30M
418.62M
-56.72M
750.60M
Income tax expense
122.20M
88.79M
27.32M
131.64M
Effective tax rate
19.82%
25.62%
40.44%
17.59%
Other operating expenses
35.23M
-1.80M
58.15M
29.98M
Net income
363.29M
232.06M
11.82M
471.18M
Net profit margin
8.09%
6.56%
0.30%
10.10%
Earnings per share
-
-
-
-
Interest and investment income
30.41M
45.55M
48.93M
70.91M
Interest expense
-31.68M
-30.03M
-28.19M
-26.08M
Net interest expenses
-1.28M
15.52M
20.74M
44.83M
Depreciation and amortization charges
-
-
-
-
EBITDA
704.03M
495.57M
18.15M
801.21M
Gain or loss from assets sale
-1.87M
1.87M
-25.11M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more